3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Neoplasms
1
COVID-19
1
Interventions
Specimen Handling
5
Observation
4
Blood Specimen Collection
4
Surveys and Questionnaires
3
Drug Therapy
3
Chemoradiotherapy
3
Surgical Procedures, Operative
2
Electrocardiography
2
Echocardiography
2
Capecitabine
2
Biopsy
2
trifluridine tipiracil drug combination
1
tegafur-gimeracil-oteracil
1
somapacitan
1
olverembatinib
1
lorlatinib
1
lenvatinib
1
gallium 68 PSMA-11
1
brexucabtagene autoleucel
1
axicabtagene ciloleucel
1
Zoledronic Acid
1
Tumor Burden
1
Telemedicine
1
Tegafur
1
Stents
1
S 1 (combination)
1
Robotic Surgical Procedures
1
Rituximab
1
Radiotherapy
1
Radiography, Panoramic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Observational
×
Telemedicine
×
Clear all
NCT04357574
2026-02-06
CORONA-SHIELD
Duke University
Enrolling by invitation
1,000 enrolled